Stellantis turnaround plan prediction market regulation Ouras IPO filing and more in Morning Squawk Bond Market Suggests Fed May Shift to Tightening Bias Under Warsh Leadership US Retail Sales Growth Slows as Consumer Sentiment Dips on Labor Market Concerns Gold Prices Hover Near 4500 as IranUS Peace Talks Take Center Stage Home Affordability Crisis A Tale of Three Owners and Soaring Costs UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potentially Reshaping Platform Regulations Saia Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings EPS Misses Estimates Amid Pipeline Progress Stock Rises 308 CRVL Q1 2026 Earnings EPS of 061 Reported Stock Declines 285 ITUB Q1 2026 Earnings EPS Misses Estimates by 17 Shares Edge Lower Mobile Infrastructure Corporation BEEP Q1 2026 Earnings Narrow EPS Beat Fails to Stem Stock Decline The Bank of New York Mellon BK Q1 2026 Earnings EPS Surpasses Expectations Amid Stable Operations T3 Defense Inc DFNS Edges Higher as Support Holds Key Levels in Focus Mainz Biomed QUCY Edges Higher on Moderate Volume Tests Key Resistance Area AFGE American Financial Group 4500 Subordinated Debentures due 2060 Holds Steady Amid FixedIncome Calm Empery Digital EMPD Pulls Back Slightly After Recent Gains Support Level in Focus Element Solutions Inc ESI Holds Near Support as Modest Decline Suggests Consolidation Phase Sacheerome Limited Shares Surge 218 from IPO Price as Profit Rises 78 Spotify Launches Legal AI Remix Feature Signaling Shift in Music Licensing Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down Indias Gen Z Cockroach Movement Gains Momentum Amid Youth Discontent Website Taken Down Data Centres Become New Frontier in Global Computing Power Arms Race Tony Blairs Call to Abandon Net Zero Draws Sharp Criticism from Energy Experts Nvidias Earnings Reveal 200 Billion Opportunity in Edge Computing Despite China Concession SPMA Q1 2026 Earnings Preferred Share Earnings Fall Short of Estimates Bicara Therapeutics BCAX Surges 4 on Renewed Buying Interest Resistance Level in Sight